Cargando…

MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making

SIMPLE SUMMARY: Next-generation sequencing (NGS) is a cutting-edge technology that enables rapid, high-throughput sequencing of DNA and RNA. Researchers and clinicians can identify genetic mutations, gene fusions, and other alterations that may drive cancer growth. This is particularly important in...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzger, Patrick, Hess, Maria Elena, Blaumeiser, Andreas, Pauli, Thomas, Schipperges, Vincent, Mertes, Ralf, Christoph, Jan, Unberath, Philipp, Reimer, Niklas, Scheible, Raphael, Illert, Anna L., Busch, Hauke, Andrieux, Geoffroy, Boerries, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340358/
https://www.ncbi.nlm.nih.gov/pubmed/37444566
http://dx.doi.org/10.3390/cancers15133456
_version_ 1785072060147433472
author Metzger, Patrick
Hess, Maria Elena
Blaumeiser, Andreas
Pauli, Thomas
Schipperges, Vincent
Mertes, Ralf
Christoph, Jan
Unberath, Philipp
Reimer, Niklas
Scheible, Raphael
Illert, Anna L.
Busch, Hauke
Andrieux, Geoffroy
Boerries, Melanie
author_facet Metzger, Patrick
Hess, Maria Elena
Blaumeiser, Andreas
Pauli, Thomas
Schipperges, Vincent
Mertes, Ralf
Christoph, Jan
Unberath, Philipp
Reimer, Niklas
Scheible, Raphael
Illert, Anna L.
Busch, Hauke
Andrieux, Geoffroy
Boerries, Melanie
author_sort Metzger, Patrick
collection PubMed
description SIMPLE SUMMARY: Next-generation sequencing (NGS) is a cutting-edge technology that enables rapid, high-throughput sequencing of DNA and RNA. Researchers and clinicians can identify genetic mutations, gene fusions, and other alterations that may drive cancer growth. This is particularly important in precision oncology as it is applied in the context of Molecular Tumor Boards (MTBs). The latter are multidisciplinary teams of experts who use NGS and bioinformatics tools to analyze patients’ genetic profiles and develop personalized treatment recommendations for cancer patients. Thus, a crucial process for MTB decision-making is the analysis, compilation, and presentation of high-dimensional sequencing data, which are used for both preparation of and case presentation to all stakeholders. MIRACUM-Pipe precisely addresses these requirements and offers an easy-to-use, one-prompt standardized solution to analyze NGS data, including quality control, variant calling, copy number estimation, annotation, visualization, and report generation. ABSTRACT: (1) Background: Next-generation sequencing (NGS) of patients with advanced tumors is becoming an established method in Molecular Tumor Boards. However, somatic variant detection, interpretation, and report generation, require in-depth knowledge of both bioinformatics and oncology. (2) Methods: MIRACUM-Pipe combines many individual tools into a seamless workflow for comprehensive analyses and annotation of NGS data including quality control, alignment, variant calling, copy number variation estimation, evaluation of complex biomarkers, and RNA fusion detection. (3) Results: MIRACUM-Pipe offers an easy-to-use, one-prompt standardized solution to analyze NGS data, including quality control, variant calling, copy number estimation, annotation, visualization, and report generation. (4) Conclusions: MIRACUM-Pipe, a versatile pipeline for NGS, can be customized according to bioinformatics and clinical needs and to support clinical decision-making with visual processing and interactive reporting.
format Online
Article
Text
id pubmed-10340358
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103403582023-07-14 MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making Metzger, Patrick Hess, Maria Elena Blaumeiser, Andreas Pauli, Thomas Schipperges, Vincent Mertes, Ralf Christoph, Jan Unberath, Philipp Reimer, Niklas Scheible, Raphael Illert, Anna L. Busch, Hauke Andrieux, Geoffroy Boerries, Melanie Cancers (Basel) Article SIMPLE SUMMARY: Next-generation sequencing (NGS) is a cutting-edge technology that enables rapid, high-throughput sequencing of DNA and RNA. Researchers and clinicians can identify genetic mutations, gene fusions, and other alterations that may drive cancer growth. This is particularly important in precision oncology as it is applied in the context of Molecular Tumor Boards (MTBs). The latter are multidisciplinary teams of experts who use NGS and bioinformatics tools to analyze patients’ genetic profiles and develop personalized treatment recommendations for cancer patients. Thus, a crucial process for MTB decision-making is the analysis, compilation, and presentation of high-dimensional sequencing data, which are used for both preparation of and case presentation to all stakeholders. MIRACUM-Pipe precisely addresses these requirements and offers an easy-to-use, one-prompt standardized solution to analyze NGS data, including quality control, variant calling, copy number estimation, annotation, visualization, and report generation. ABSTRACT: (1) Background: Next-generation sequencing (NGS) of patients with advanced tumors is becoming an established method in Molecular Tumor Boards. However, somatic variant detection, interpretation, and report generation, require in-depth knowledge of both bioinformatics and oncology. (2) Methods: MIRACUM-Pipe combines many individual tools into a seamless workflow for comprehensive analyses and annotation of NGS data including quality control, alignment, variant calling, copy number variation estimation, evaluation of complex biomarkers, and RNA fusion detection. (3) Results: MIRACUM-Pipe offers an easy-to-use, one-prompt standardized solution to analyze NGS data, including quality control, variant calling, copy number estimation, annotation, visualization, and report generation. (4) Conclusions: MIRACUM-Pipe, a versatile pipeline for NGS, can be customized according to bioinformatics and clinical needs and to support clinical decision-making with visual processing and interactive reporting. MDPI 2023-07-01 /pmc/articles/PMC10340358/ /pubmed/37444566 http://dx.doi.org/10.3390/cancers15133456 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Metzger, Patrick
Hess, Maria Elena
Blaumeiser, Andreas
Pauli, Thomas
Schipperges, Vincent
Mertes, Ralf
Christoph, Jan
Unberath, Philipp
Reimer, Niklas
Scheible, Raphael
Illert, Anna L.
Busch, Hauke
Andrieux, Geoffroy
Boerries, Melanie
MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title_full MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title_fullStr MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title_full_unstemmed MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title_short MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making
title_sort miracum-pipe: an adaptable pipeline for next-generation sequencing analysis, reporting, and visualization for clinical decision making
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340358/
https://www.ncbi.nlm.nih.gov/pubmed/37444566
http://dx.doi.org/10.3390/cancers15133456
work_keys_str_mv AT metzgerpatrick miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT hessmariaelena miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT blaumeiserandreas miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT paulithomas miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT schippergesvincent miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT mertesralf miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT christophjan miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT unberathphilipp miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT reimerniklas miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT scheibleraphael miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT illertannal miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT buschhauke miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT andrieuxgeoffroy miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking
AT boerriesmelanie miracumpipeanadaptablepipelinefornextgenerationsequencinganalysisreportingandvisualizationforclinicaldecisionmaking